The Current Ratio as of December 2024 (TTM) for Icosavax, Inc. (ICVX) is 18.06

According to Icosavax, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.06. This represents a change of 8.24% compared to the average of 16.68 of the last 4 quarters.

Icosavax, Inc. (ICVX) Historical Current Ratio (quarterly & annually)

How has ICVX Current Ratio performed in the past?

The mean historical Current Ratio of Icosavax, Inc. over the last ten years is 17.27. The current 18.06 Current Ratio has changed 10.36% with respect to the historical average. Over the past ten years (40 quarters), ICVX's Current Ratio was at its highest in in the September 2021 quarter at 36.67. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Icosavax, Inc. (ICVX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Icosavax, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Icosavax, Inc. (ICVX) Average Current Ratio

How has ICVX Current Ratio performed in the past?

The current Current Ratio of Icosavax, Inc. (ICVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Icosavax, Inc. (ICVX) Current Ratio vs. Peers

How is ICVX’s Current Ratio compared to its peers?

Icosavax, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (32.99), greater than Amylyx Pharmaceuticals, Inc. (4.55), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than Inozyme Pharma, Inc. (7.68), greater than X4 Pharmaceuticals, Inc. (4.89), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than Eledon Pharmaceuticals, Inc. (6.53), greater than HOOKIPA Pharma Inc. (3.26), greater than Mereo BioPharma Group plc (6.10), greater than PDS Biotechnology Corporation (2.84), greater than Immix Biopharma, Inc. (3.47), greater than CNS Pharmaceuticals, Inc. (1.82), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than Freeline Therapeutics Holdings plc (1.95), less than AVROBIO, Inc. (26.17),

Build a custom stock screener for Icosavax, Inc. (ICVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Icosavax, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Icosavax, Inc. (ICVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Icosavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.